VAŠKŮ, Anna, Jiří BLAHÁK, Daniel BAUMGARTNER and Julie BIENERTOVÁ VAŠKŮ. Angiotensin Converting Enzyme I/D Polymorphism and Cardiovascular Risk: Disclosed Story. In Genes and Cardiovascular Function. 1st Edition. Neuveden: Springer, 2011, p. 121-134. ISBN 978-1-4419-7206-4. Available from: https://dx.doi.org/10.1007/978-1-4419-7207-1_13.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Angiotensin Converting Enzyme I/D Polymorphism and Cardiovascular Risk: Disclosed Story
Authors VAŠKŮ, Anna (203 Czech Republic, guarantor, belonging to the institution), Jiří BLAHÁK (203 Czech Republic, belonging to the institution), Daniel BAUMGARTNER (203 Czech Republic, belonging to the institution) and Julie BIENERTOVÁ VAŠKŮ (203 Czech Republic, belonging to the institution).
Edition 1st Edition. Neuveden, Genes and Cardiovascular Function, p. 121-134, 14 pp. 2011.
Publisher Springer
Other information
Original language English
Type of outcome Chapter(s) of a specialized book
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Publication form printed version "print"
WWW URL
RIV identification code RIV/00216224:14110/11:00064829
Organization unit Faculty of Medicine
ISBN 978-1-4419-7206-4
Doi http://dx.doi.org/10.1007/978-1-4419-7207-1_13
UT WoS 000294269500013
Keywords in English CAD; diabetes mellitus; ACE I/D
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 17/4/2013 15:56.
Abstract
Rapid advances in molecular medicine have led to pronounced new developments in experimental and clinical cardiology. In the embrace of modern molecular biology and bridging the gap between the clinical and the genomic, cardiovascular medicine has seen major strides in the understanding of the molecular mechanisms that drive disease progression. The ability to rapidly identify candidate human genes for cardiovascular diseases lends itself to the development of diverse strategies for disease treatment and management. The wide variety of gene expressions proffers excellent targets for novel therapeutics. Gene therapy is steadily increasing in viability and represents a fascinating arena of research and clinical focus.
Links
NS10206, research and development projectName: Asociace polymorfismů v genech pro metaloproteinázy, jejich inhibitory, ACE a ACE2 s centrálním pulsním tlakem u kardiovaskulárních pacientů
Investor: Ministry of Health of the CR
PrintDisplayed: 23/7/2024 01:14